Myeloid/lymphoid neoplasms with ZBTB44-FLT3 rearrangement

2021-09-23   Sheng Xiao, MD 

1.Brigham and Women's Hospital

Abstract

ZBTB44-FLT3 rearrangement was found in a patient with MPN and eosinophilia. His clinicalpathologic findings were consistent with myeloid/lymphoid neoplasms with receptor tyrosine kinase receptor (RTK) rearrangement.

Keywords
MPN,FLT3,Eosinophilia

Clinics and Pathology

Etiology

Unknown

Epidemiology

Rare disease with unknown incidence

Clinics

A 64-year-old male presented with fatigue and weight loss for three months. Physical examination found a enlarged spleen (6 cm below the left costal margin) but was negative for adenopathy, bruise/bleed and hepatomegaly. Peripheral blood counts demonstrated leukocytosis and thrombocytopenia with white blood cells (WBC) 128·68 × 109/l, haemoglobin (HGB) 137 g/l and platelet count 36 × 109/l. A differential count found 35·6% neutrophils, 14·2% lymphocytes, 13·3% monocytes, 3% basophils, 1% myelocytes and 32·6% eosinophils (absolute eosinophil count 43 × 109/l).

Cytology

Bone marrow aspiration smears showed marked granulocytic proliferation, with a myeloid-to-erythroid ratio of 34.8:1. Myeloblasts and promyelocytes were not increased. Eosinophils were significantly increased, accounting for 31% of all nucleated cells, with some of them showing sparse granulation and cytoplasmic vacuolation. Erythroid and lymphoid elements were markedly proportionally decreased with no significant dysplasia.


Fig. 1: Eosinophilia with cytoplasmic vacuolation

Genes Involved and Proteins

Cytogenetics

46,XY,t(11;13)(q24;q12[20]



Fig. 2 Karyotype of bone marrow showed a balanced translocation between chromosome 11 and 13  in all cells as the sole change.


Additional anomalies/variants

None.

Most similar cases involving FLT3 rearrangement do not have additional chromosome aberrations.

Result of the Chromosomal Anomaly

Hybrid gene

The fusion can be detected by karyotype, FISH, RT-PCR, or targeted RNA NGS.

Fusion protein

The expected fusion protein contains an intact BTB/POZ domain and the FLT3 tyrosine kinase domain (TKD). The ZBTB44-FLT3 fusion protein is likely constitutively activated by ZBTB4 BTB/POZ-induced erization and cross-phosphorylation by the FLT3 tyrosine kinase.

Fig. 5   Functional motifs of ZBTB44, FLT3 and ZBTB44-FLT3 fusion. BTB: broad-complex, tramtrack and bric a brac, also known as the POZ domain; ZF, zinc fingers; IG-like, immunoglobulin-like loops; TM, transmembrane domain; TK, tyrosine kinase domain.

Expression localisation

Cytoplasm

Bibliography

No bibliography items were found for this article.

Citation

Sheng Xiao, MD

Myeloid/lymphoid neoplasms with ZBTB44-FLT3 rearrangement

Atlas Genet Cytogenet Oncol Haematol. 2021-09-23

Online version: http://atlasgeneticsoncology.org/haematological/208959/files/files/1632427178_image.png